Aciculatin inhibits lipopolysaccharide-mediated inducible nitric oxide synthase and cyclooxygenase-2 expression via suppressing NF-B and JNK/p38 MAPK activation pathways

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Hsieh, I Ni ^a   Chang, Anita Shin Yuan ^a   Teng, Che Ming ^a   Chen, Chien Chih ^b   Yang, Chia Ron ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b HUNGKUANG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACICULATIN; CHRYSOPOGON ACICULATIS EXTRACT; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRATE; NITRIC OXIDE; PLANT EXTRACT; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; CYCLOOXYGENASE 2 INHIBITOR; FLAVONOID; MITOGEN ACTIVATED PROTEIN KINASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CHRYSOPOGON ACICULATIS; CONCENTRATION RESPONSE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME REPRESSION; GENE EXPRESSION; MACROPHAGE ACTIVATION; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; ENZYMOLOGY; MACROPHAGE; METABOLISM;

CHRYSOPOGON;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; FLAVONOIDS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II;

EID: 79955665002     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-28     Document Type: Article

References (46)

1. Aciculatin, a novel flavon-c-glycoside with DNA binding activity from Chrysopogon Aciculatis. BK Carte S Carr C DeBrosse ME Hemling L MacKenzie P Offen DE Berry, Tetrahedron 1991 47 1815 1822 10.1016/S0040-4020(01)96096-X
2. Induction of nitric oxide synthase and dual effects of nitric oxide and cyclooxygenase products in regulation of arterial contraction in human septic shock. JC Stoclet MC Martínez P Ohlmann S Chasserot C Schott AL Kleschyov F Schneider R Andriantsitohaina, Circulation 1999 100 107 112 10402437 (Pubitemid 29330006)
3. NO role of NOS2A susceptibility polymorphisms in rheumatoid arthritis. J Varade JR Lamas M Fernndez-Arquero JA Jover EG de la Concha A Martinez B Fernandez-Gutierrez E Urcelay, Nitric Oxide 2009 21 171 174 10.1016/j.niox.2009. 07.005 19635578
4. Targeted therapies in osteoarthritis: a systematic review of the trials on http:// www.clinicaltrials.gov. F Berenbaum, Best Pract Res Clin Rheumatol 2010 24 107 119 10.1016/j.berh.2009.08.007 20129204
5. Cyclooxygenase-2/prostaglandin D2/CRTH2 pathway mediates double-stranded RNA-induced enhancement of allergic airway inflammation. Y Shiraishi K Asano K Niimi K Fukunaga M Wakaki J Kagyo T Takihara S Ueda T Nakajima T Oguma Y Suzuki T Shiomi K Sayama S Kagawa E Ikeda H Hirai K Nagata M Nakamura T Miyasho A Ishizaka, J Immunol 2008 180 541 549 18097056
6. Role of inducible nitric oxide synthase and cyclooxygenase-2 in endotoxin-induced cerebral hyperemia. H Okamoto O Ito RJ Roman AG Hudetz, Stroke 1998 29 1209 1218 9626296 (Pubitemid 28265479)
7. LPS induction of gene expression in human monocytes. M Guha N Mackman, Cell Signal 2001 13 85 94 10.1016/S0898-6568(00)00149-2 11257452 (Pubitemid 32222977)
8. Effects of nitric oxide and nitric oxide-derived species on prostaglandin endoperoxide synthase and prostaglandin biosynthesis. DC Goodwin LM Landino LJ Marnett, FASEB J 1999 13 1121 1136 10385604 (Pubitemid 29300359)
9. Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2. SF Kim DA Huri SH Snyder, Science 2005 310 1966 1970 10.1126/science.1119407 16373578 (Pubitemid 43005992)
10. The mechanism of action of aspirin. JR Vane RM Botting, Thromb Res 2003 110 255 258 10.1016/S0049-3848(03)00379-7 14592543 (Pubitemid 37329821)
11. Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. JD Erusalimsky S Moncada, Arterioscler Thromb Vasc Biol 2007 27 2524 2531 10.1161/ATVBAHA.107.151167 17885213 (Pubitemid 350158901)
12. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. V Mollace C Muscoli E Masini S Cuzzocrea D Salvemini, Pharmacol Rev 2005 57 217 252 10.1124/pr.57.2.1 15914468 (Pubitemid 41043885)
13. Interaction between nitric oxide and cyclooxygenase pathways in endothelial cells. C Vassalle C Domenici V Lubrano A L'Abbate, J Vasc Res 2003 40 491 499 10.1159/000074550 14583660 (Pubitemid 37465097)
14. Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk. V Sibilia F Pagani G Rindi N Lattuada D Rapetti V De Luca N Campanini I Bulgarelli V Locatelli F Guidobono C Netti, Br J Pharmacol 2008 154 688 697 10.1038/bjp.2008.120 18414388 (Pubitemid 351744947)
15. Transcriptional control of the inflammatory response. R Medzhitov T Horng, Nat Rev Immunol 2009 9 692 703 10.1038/nri2634 19859064
16. Signaling transduction: target in osteoarthritis. F Berenbaum, Curr Opin Rheumatol 2004 16 616 622 10.1097/01.bor.0000133663.37352.4a 15314504 (Pubitemid 39128334)
17. Molecular cloning and expression of an avian macrophage nitric-oxide synthase cDNA and the analysis of the genomic 5'-flanking region. AW Lin CC Chang CC McCormick, J Biol Chem 1996 271 11911 11919 10.1074/jbc.271.20.11911 8662618
18. Structure of the human cyclo-oxygenase-2 gene. SB Appleby A Ristimaki K Neilson K Narko T Hla, Biochem J 1994 302 723 727 7945196 (Pubitemid 24289307)
19. Structure, Regulation and Function of NF-B. U Siebenlist G Franzoso K Brown, Annu Rev Cell Bioi 1994 10 405 455 10.1146/annurev.cb.10.110194.002201
20. Phosphorylation Meets Ubiquitination: The Control of NF-B Activity. M Karin Y Ben-Neriah, Annu Rev Immunol 2000 18 621 663 10.1146/annurev.immunol.18. 1.621 10837071 (Pubitemid 30365393)
21. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. GL Johnson R Lapadat, Science 2002 298 1911 1912 10.1126/science.1072682 12471242 (Pubitemid 35425238)
22. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. QW Xie Y Kashiwabara C Nathan, J Biol Chem 1994 269 4705 4708 7508926 (Pubitemid 24239438)
23. Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. PJ Barnes M Karin, N Engl J Med 1997 336 1066 1071 10.1056/NEJM199704103361506 9091804 (Pubitemid 27163860)
24. Endotoxin induction of nitric oxide synthase and cyclooxygenase-2 in equine alveolar macrophages. RA Hammond R Hannon SP Frean SJ Armstrong RJ Flower CE Bryant, Am J Vet Res 1999 60 426 431 10211684 (Pubitemid 129535496)
25. 2, and cytokine production in endotoxin-activated macrophages. YH Huang PS Tsai CJ Huang, Acta Anaesthesiol Scand 2008 52 530 535 10.1111/j.1399-6576.2008.01590.x 18339158 (Pubitemid 351392867)
26. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. CC Wu SJ Chen C Szabo C Thiemermann JR Vane, Br J Pharmacol 1995 114 1666 1672 7541282
27. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. L Liaudet A Rosselet MD Schaller M Markert C Perret F Feihl, J Infect Dis 1998 177 127 132 10.1086/513813 9419179 (Pubitemid 28030443)
28. Reactive oxygen species- and nitric oxide-mediated lung inflammation and mitochondria dysfunction in wild-type and iNOS-deficient mice exposed to diesel exhaust particles. H Zhao JK Ma MW Barger RR Mercer L Millecchia D Schwegler-Berry V Castranova JY Ma, J Toxicol Environ Health A 2009 72 560 570 10.1080/15287390802706330 19267316
29. Helminth antigen-based strategy to ameliorate inflammation in an experimental model of colitis. Y Motomura H Wang Y Deng RT El-Sharkawy EF Verdu WI Khan, Clin Exp Immunol 2009 155 88 95 10.1111/j.1365-2249.2008.03805.x 19016806
30. Regulation of prostaglandin production by nitric oxide; an in vivo analysis. D Salvemini SL Settle JL Masferrer K Seibert MG Currie P Needleman, Br J Pharmacol 1995 114 1171 1178 7542531
31. Nitric oxide activates cyclooxygenase enzymes. D Salvemini TP Misko JL Masferrer K Seibert MG Currie P Needleman, Proc Natl Acad Sci USA 1993 90 7240 7244 10.1073/pnas.90.15.7240 7688473 (Pubitemid 23222425)
32. 2athrough nitric oxide-induced S-nitrosylation. Involvement of inducible nitric-oxide synthase and cyclooxygenase-2. L Xu C Han K Lim T Wu, J Biol Chem 2008 283 3077 3087 18029351
33. L-N6-(1-Iminoethyl)lysine: a selective inhibitor of inducible NO synthease. WM Moore RK Webber GM Jerome FS Tjoeng TP Misko MG Currie, J Med Chem 1994 37 3886 3888 10.1021/jm00049a007 7525961 (Pubitemid 24379677)
34. Suppression of adjuvant-induced arthritis by selective inhibition of inducible NO synthase. JR Connor PT Manning SL Settle WM Moore GM Jerome RK Webber FS Tjoeng MG Currie, Eur J Pharmacol 1995 273 15 24 10.1016/0014-2999(94) 00672-T 7537678
35. Cyclooxygenase inhibition decreases nitric oxide synthase activity in human platelets. LY Chen MN Salafranca JL Metha, Am J Physiol 1997 273 1854 H1859 9362253
36. In vivo study on cross talk between inducible nitric-oxide synthase and cyclooxygenase in rat gastric mucosa; effect of cyclooxygenase activity on nitric oxide production. K Uno Y Iuchi J Fujii H Sugata K Iijima K Kato T Shimosegawa T Yoshimura, J Pharmacol Exp Ther 2004 309 995 1002 10.1124/jpet.103.061283 14988416 (Pubitemid 38669685)
37. Aciculatin, a novel flavones-c-glycyside with DNA binding activity from Chrysopogon Aciculatis. BK Carte S Carr C DeBrosse ME Hemling L MacKenzie P Offen DE Berry, Tetrahedron 1991 10/11 1815 1822
38. Transcriptional control of the inflammatory response. R Medzhitov T Horng, Nat Rev Immunol 2009 9 692 703 10.1038/nri2634 19859064
39. New regulators of NF-B in inflammation. S Ghosh MS Hayden, Nat Rev Immunol 2008 8 837 848 10.1038/nri2423 18927578
40. Toll-like receptor signalling. S Akira K Takeda, Nat Rev Immunol 2004 4 499 511 10.1038/nri1391 15229469 (Pubitemid 38931765)
41. Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. A Grandjean-Laquerriere SC Gangloff R Le Naour C Trentesaux W Hornebeck M Guenounou, Cytokine 2002 18 168 177 10.1006/cyto.2002.0888 12126654 (Pubitemid 34775439)
42. Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. CJ Lowenstein EW Alley P Raval AM Snowman SH Snyder SW Russell WJ Murphy, Proc Natl Acad Sci USA 1993 90 9730 9734 10.1073/pnas.90.20.9730 7692452 (Pubitemid 23315860)
43. Anti-inflammatory effects of short chain fatty acids in IFN - stimulated RAW 264.7 murine macrophage cells: Involvement of NF-B and ERK signaling pathways. JS Park EJ Lee JC Lee WK Kim HS Kim, Int Immunopharmacol 2007 7 70 77 10.1016/j.intimp.2006.08.015 17161819
44. LPS induction of gene expression in human monocytes. M Guha N Mackman, Cell Signal 2001 13 85 94 10.1016/S0898-6568(00)00149-2 11257452 (Pubitemid 32222977)
45. Wogonin but not Nor-wogonin inhibits lipopolysaccharide and lipoteichoic acid-induced iNOS gene expression and NO production in macrophages. GC Huang JM Chow SC Shen LY Yang CW Lin YC Chen, Int Immunopharmacol 2007 7 1054 1063 10.1016/j.intimp.2007.04.001 17570322
46. Rosmanol potently inhibits lipopolysaccharide-induced iNOS and COX-2 expression through downregulating MAPK, NF-B, STAT3 and C/EBP signaling pathways. CS Lai JH Lee CT Ho CB Liu JM Wang YJ Wang MH Pan, J Agric Food Chem 2009 57 10990 10998 10.1021/jf9025713 19856917